You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
24 January 2022
Acquisitions and new in-licensing agreements helped lift sales at Galenica’s Products & Brands business – which mainly consists of the Verfora consumer healthcare unit – by 17.8% to CHF132 million (USD142 million) in 2021.
1 December 2021
Galenica is adding digital expertise to its Executive Committee, Venture Life has announced senior management changes, and Perrigo is set to get a new chairman.
2 July 2021
Switzerland’s Galenica is boosting the Verfora consumer healthcare business in its home market by acquiring phytotherapy and complementary medicines specialist Spagyros for an undisclosed sum.
3 June 2021
Switzerland’s Galenica has boosted its Verfora consumer healthcare business by acquiring a portfolio of brands – including Vitamin D3 Wild Oil and VI-DE 3 – from Swiss company Dr. Wild & Co for an undisclosed sum.
21 January 2021
New distribution agreements and acquisitions helped lift sales at Galenica’s Products & Brands business, which mainly consists of the Verfora consumer healthcare unit, by 9.4% to CHF112 million (USD126 million) in 2020.
1 December 2020
Galenica, which owns the Verfora consumer healthcare business, is reorganising from 1 January 2021 in a move that should allow it to “develop new products and services more efficiently with shorter time-to-market”.